INHIBITION OF PROLACTIN AND ALDOSTERONE SECRETION BY THE DOPAMINE DERIVATIVE IBOPAMINE

被引：28

作者：

ROLANDI, E ^{[1
]}

MARCHETTI, G ^{[1
]}

FRANCESCHINI, R ^{[1
]}

CICCHETTI, V ^{[1
]}

GIANROSSI, R ^{[1
]}

CANTONI, V ^{[1
]}

BARRECA, T ^{[1
]}

机构：

[1] UNIV GENOA, DEPT INTERNAL MED, I-16126 GENOA, ITALY

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 29卷 / 05期

关键词：

D O I：

10.1007/BF00635905

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：629 / 630

页数：2

共 17 条

[1]

AGUILERA G, 1983, FRONT NEUROENDOCRIN, V8, P265

[2] NON-INVASIVE EVALUATION OF THE EFFECTS OF ORAL IBOPAMINE (SB-7505) ON CARDIAC AND RENAL-FUNCTION IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].

CAS, LD ;

MANCA, C ;

BERNARDINI, B ;

VASINI, G ;

VISIOLI, O .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :436-440

[3] IBOPAMINE IN VERY SEVERE CONGESTIVE HEART-FAILURE - PILOT HEMODYNAMIC INVASIVE ASSESSMENT [J].

COL, J ;

MIEVIS, E ;

REYNAERT, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (03) :297-300

[4]

CROSIGNANI PG, 1976, LANCET, V2, P975

[5]

DELPOZO E, 1972, J CLIN ENDOCR METAB, V35, P768, DOI 10.1210/jcem-35-5-768

[6]

DELPOZO E, 1978, FRONT NEUROENDOCRIN, P207

[7] EFFECTS OF IBOPAMINE ON SERUM PROLACTIN AND GROWTH-HORMONE LEVELS IN HYPERPROLACTINEMIC AND ACROMEGALIC SUBJECTS [J].

FERRARI, C ;

BARBIERI, C ;

CALDARA, R ;

RAMPINI, P ;

PARACCHI, A ;

BOGHEN, M ;

RAUHE, WG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :74-78

[8] EVIDENCE FOR DOPAMINERGIC CONTROL OF ALDOSTERONE IN MAN [J].

FRISINA, N ;

COSTA, G ;

BUEMI, M .

CLINICAL ENDOCRINOLOGY, 1983, 19 (06) :741-745

[9] COMPARISON OF VASCULAR DOPAMINE RECEPTOR WITH OTHER DOPAMINE RECEPTORS [J].

GOLDBERG, LI ;

VOLKMAN, PH ;

KOHLI, JD .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1978, 18 :57-79

[10] EFFECT OF THE ORALLY ABSORBED DOPAMINE ANALOG N-METHYLDOPAMINE DIISOBUTYRIC ESTER ON PLASMA PROLACTIN LEVELS [J].

LOMBARDI, G ;

TOMMASELLI, A ;

FARIELLO, C ;

QUATTRONE, A ;

ANNUNZIATO, L .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (01) :131-133

← 1 2 →